Package Leaflet: Information for the User
ASPIRINA COMPLEX Effervescent Granules
Acetylsalicylic Acid, Phenylephrine, Chlorphenamine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Follow the instructions for administration of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.
|
Contents of the Package Leaflet
ASPIRINA COMPLEX Effervescent Granules are an association of acetylsalicylic acid, an analgesic that acts on pain and fever, chlorphenamine, an antihistamine that reduces sneezing and tearing, and phenylephrine, a vasoconstrictor that acts on nasal congestion.
This medicine is indicated for the symptomatic relief of catarrhal and flu-like processes that occur with mild or moderate pain, fever, congestion, and nasal secretion in adults and adolescents over 16 years of age.
Do not take ASPIRINA COMPLEX Effervescent Granules if:
Be especially careful with ASPIRINA COMPLEX Effervescent Granules:
Before taking this medicine, you should consult your doctor if:
Use of other medications
Inform your doctor or pharmacist if you are using or have recently used other medications, including those purchased without a prescription, homeopathic, herbal, and other health-related products, as it may be necessary to interrupt treatment or adjust the dose of one of them.
Due to its content of acetylsalicylic acid, it may interact with the following medications:
Additionally, this medicine may interact with other medications such as: medications to lower blood pressure (antihypertensives), nasal decongestants, antidepressants, stimulants, sedatives, tranquilizers, and depressants of the nervous system, so you should consult your doctor or pharmacist if you are taking these medications.
Due to its content of Phenylephrine, if you are being treated with some of the following medications or with ASPIRINA COMPLEX, it may be necessary to interrupt treatment or separate administration by at least 15 days:
- Alpha and beta-adrenergic blockers such as labetalol and carvedilol (used for the heart or arterial diseases).
Due to its content of Chlorphenamine, simultaneous use with the following medications may potentiate the production of side effects:
- Monoamine oxidase inhibitors (MAOIs) used to treat depression (tranilcipromine, moclobemide) or Parkinson's disease (selegiline), severe side effects may occur, which manifest as severe headache, elevated blood pressure, and sudden elevation of temperature. If you have taken one of these medications, wait at least 15 days before taking ASPIRINA COMPLEX. If you are not sure if your medication contains an MAOI, consult your doctor or pharmacist before taking ASPIRINA COMPLEX Effervescent Granules.
- Tricyclic and tetracyclic antidepressants.
Interference with analytical tests:
It may interfere with skin tests that use allergens. It is recommended to suspend taking this medication at least 3 days before starting the tests and inform the doctor.
If you are going to have any diagnostic tests (including blood tests, urine tests, etc.), inform your doctor that you are taking this medication, as it may alter the results.
Taking ASPIRINA COMPLEX Effervescent Granules with food and drinks
Take this medication after meals or with some food.
Do not take this medication on an empty stomach.
Always use the smallest effective dose.
The administration of this medication is subject to the appearance of symptoms, pain, fever, congestion, and nasal secretion. As these symptoms disappear, this medication should be suspended.
If the fever continues after 3 days of treatment, or the symptoms worsen or do not improve after 5 days, or other symptoms appear, you should interrupt treatment and consult your doctor.
If you take more ASPIRINA COMPLEX Effervescent Granules than you should
If you take more ASPIRINA COMPLEX than you should, you may notice the following symptoms: nausea, vomiting, ringing in the ears, deafness, sweating, vasodilation, and hyperventilation, headache, blurred vision, mental confusion, and occasionally diarrhea, excessive nervous stimulation, anxiety, fear, agitation, headache (may be a symptom of hypertension), convulsions, insomnia, confusion, irritability, tremors, anorexia (loss of appetite), psychosis with hallucinations (more frequent in children), and effects on the cardiovascular system such as hypertension, cerebral hemorrhage, and pulmonary edema, peripheral vasoconstriction with possible reduction of blood flow to vital organs (severe effects may appear more likely in hypovolemic patients, i.e., with decreased blood volume, due to bleeding, dehydration, etc.), severe bradycardia (slow heartbeats), increased heart rate, irregular or rapid heartbeats, decreased urine output, metabolic acidosis (decrease in blood alkaline reserve), paresthesias (sensitivity alterations in body areas). In prolonged use, it may cause plasma volume depletion (decrease in blood volume), instability, intense numbness, severe dryness of the mouth, nose, or throat, facial flushing, dyspnea (difficulty breathing), cardiac arrhythmias (rapid or irregular heartbeats), nervous stimulation (hallucinations, convulsions), these latter symptoms may appear late, hypotension (feeling of fainting).
There is no antidote for salicylate poisoning. In case of suspected overdose, the patient should be kept under observation for at least 24 hours, as symptoms and salicylate levels in the blood may not be evident for several hours.
Overdose is treated with gastric lavage, forced alkaline diuresis, and supportive therapy. It may be necessary to restore acid-base balance along with hemodialysis in acute cases. The treatment of overdose of chlorphenamine and phenylephrine is symptomatic and supportive.
It is recommended to bring the package and package leaflet of the medication to the healthcare professional.
In case of overdose or accidental ingestion, go to a medical center immediately, consult your doctor or pharmacist immediately, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take ASPIRINA COMPLEX Effervescent Granules
Do not take a double dose to make up for forgotten doses. Take it again as indicated in section 3. How to take ASPIRINA COMPLEX.
Follow these instructions unless your doctor has given you different instructions.
Consult your doctor or pharmacist if you have doubts.
The normal dose is:
Adults and adolescents over 16 years of age:
The dose is 1 sachet every 8 hours and if necessary every 6 hours.
The maximum daily dose is 4 sachets with a minimum interval of 6 hours between each intake.
Children:
Do not use this medication in children under 16 years of age.
Patient with reduced liver or kidney function: consult your doctor as the dose should be reduced.
This medication is administered orally.
Dissolve the entire contents of a sachet preferably in a glass of water and drink the entire contents of the glass when the bubbling has completely stopped.
Take the medication after meals or with some food, especially if you notice stomach discomfort.
Do not take this medication on an empty stomach.
Always use the smallest effective dose.
The administration of this medication is subject to the appearance of symptoms, pain, fever, congestion, and nasal secretion. As these symptoms disappear, this medication should be suspended.
If the fever continues after 3 days of treatment, or the symptoms worsen or do not improve after 5 days, or other symptoms appear, you should interrupt treatment and consult your doctor.
Like all medicines, ASPIRINA COMPLEX effervescent granule can cause adverse effects, although not all people suffer from them.
Frequent adverse effects(observed between 1 and 10 out of every 100 people):
Uncommon adverse effects (observed between 1 and 100 out of every 1000 people):
With prolonged doses of acetylsalicylic acid, the following adverse effects have been observed, whose frequency has not been established with precision: dizziness, ringing in the ears, deafness, sweating, headache, confusion, renal insufficiency, and acute interstitial nephritis (inflammation at the kidney level).
If you observe the appearance of any of the following symptoms, stop taking the medicine and consult your doctor immediately, as they may indicate the onset of side effects that require urgent medical attention:
Adverse effects due to phenylephrine:
-With unknown frequency: anxiety, nervousness, irritability, weakness, dizziness, tremors, insomnia, hypertension (increase in blood pressure) (usually with high doses and in sensitive patients), headache (with high doses and may be a symptom of hypertension), chest pain or discomfort, severe bradycardia (very slow heartbeats), peripheral vasoconstriction (reduction of blood vessel caliber), reduction of heart performance that especially affects the elderly and patients with poor cerebral or coronary circulation, possible production or worsening of heart disease, urinary retention, breathing difficulties, paleness, goosebumps, increased sweating, hyperglycemia (increase in blood sugar), decrease in potassium in the blood, metabolic acidosis, coldness in the extremities (legs or arms), flushing, hypotension (feeling of fainting); with high doses, the following may occur: vomiting, palpitations, psychotic states with hallucinations; with prolonged use, a decrease in blood volume may occur.
Adverse effects due to chlorphenamine:
If you consider that any of the adverse effects you are suffering from is serious or if you notice any adverse effect not mentioned in this prospectus, inform your doctor or pharmacist.
Reporting of adverse effects:
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
It does not require special storage conditions.
Keep this medicine out of sight and reach of children.
Expiration date:
Do not use ASPIRINA COMPLEX effervescent granule after the expiration date that appears on the packaging, after the abbreviation CAD. The expiration date is the last day of the month indicated.
Medicines should not be thrown away through the sewers or in the trash. Deposit the packaging and medicines you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of ASPIRINA COMPLEX effervescent granule
Each sachet contains:
Appearance of the product and packaging content
This medicine is an effervescent granule. It is presented in packaging that contains 10 and 20 sachets.
Marketing authorization holder and manufacturer
Bayer Hispania, S.L. KERN PHARMA, S.L.
Av. Baix Llobregat, 3-5 Polígono Ind. Colón II
08970 Sant Joan Despí (Barcelona) C/Venus, 72
Spain 08228 Terrassa (Barcelona)
Spain
Date of the last revision of this prospectus: October 2023
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es